COMMUNIQUÉS West-GlobeNewswire

Geron Continues to Build Senior Leadership of Its Development Team
16/05/2019
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition of a Vice President, [...]
Oncology Venture has successfully executed capital increase with a value in excess of SEK 80m.
16/05/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, May 16, 2019 – Oncology Venture A/S today confirms that its capital increase consisting of shares with attached investor warrants has been successfully executed [...]
Affimed Announces First Quarter 2019 Financial Results and Corporate Update Conference Call on May 22, 2019
16/05/2019
Heidelberg, Germany, May 16, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced that it will host a [...]
111 Announces Changes to its Board of Directors
16/05/2019
SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that Dr. Leon Lian Yong Chen has been [...]
111, Inc. Announces First Quarter 2019 Unaudited Financial Results
16/05/2019
SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results [...]
Virbac : availability of the quarterly financial information as of March 31, 2019
16/05/2019
Virbac: Availability of the quarterly financial information as of March 31, 2019 Public release – May 15, 2019 The quarterly financial information as of March 31, 2019 is available: • on our website: corporate.virbac. [...]
Virbac : mise à disposition de l'information financière trimestrielle au 31 mars 2019
16/05/2019
Virbac : Mise à disposition de l’information financière trimestrielle au 31 mars 2019 Communiqué diffusé le 15 mai 2019 L’information financière trimestrielle au 31 mars 2019 est disponible : • sur notre site internet [...]
Opening of new Dutch wind farm puts Philips on course to becoming carbon neutral by 2020
16/05/2019
May 16, 2019 On-schedule opening of Windpark Krammer by Dutch monarch makes Philips’ Netherlands-based operations 100% powered by renewable energy Combined with the 100% target already achieved in the US, Philips is now [...]
LIDDS Delårsrapport januari - mars 2019
16/05/2019
JANUARI - MARS 2019 Nettoomsättningen uppgick till 0,0 (0,0) KSEK Kostnaderna uppgick till 2,5 (2,0) MSEK Resultatet före och efter skatt uppgick till -2,5 (-2,0) MSEK Resultat per aktie uppgick till -0,11 (-0,09) kr [...]
Terveystalo's network of occupational health services to expand: Terveystalo acquires Etelä-Karjalan Työkunto Oy
16/05/2019
Press Release 16 May 2019 Terveystalo will buy the operations of Etelä-Karjalan Työkunto Oy by an agreement signed on 15 May 2019. The old customer relationship remains unchanged. Etelä-Karjalan Työkunto Oy is the [...]
Novadip Biosciences to present at 20th annual Bio€quity Europe Conference
16/05/2019
Novadip Biosciences to present at 20 th annual Bio€quity Europe Conference Belgium, 16 May 2019: Novadip Biosciences (“Novadip”), a regenerative medicine company and pioneer in the development of three-dimensional [...]
AroCell AB (publ) Interim Report 1st January to 31st March 2019
16/05/2019
Word from the CEO “Biomarkers will play an increasingly important role in how we identify and follow up treatments for patients with cancer in the coming years. The development of an increased individual adaptation of [...]
Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma
16/05/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID TO TREAT ALLERGIC ASTHMA « Antibodies and Complement 2019 » - Girona, [...]
Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde pour le traitement de l'asthme allergique
16/05/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES R É SULTATS PR É CLINIQUES DE SON CANDIDAT VACCIN TH É RAPEUTIQUE IL-4/IL-13 KINO Ϊ DE POUR LE TRAITEMENT DE L’ASTHME ALLERGIQUE « [...]
ObsEva SA to Participate in Upcoming Investor Conferences
16/05/2019
Geneva, Switzerland and Boston, MA – May 16, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Renaissance BioScience files PCT Patent Application for Yeast-based RNA Bioactive Molecule Production and Delivery Technology Platform
16/05/2019
VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp., a leading biological engineering company, is pleased to announce the filing on May 8, 2019 of a PCT patent application for a [...]
“CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria
16/05/2019
Interim Report, January – March 2019 Malmö, May 16, 2019 “CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in [...]
Biocartis Group NV: Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference
16/05/2019
PRESS RELEASE : 16 May 2019, 07:00 CEST Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference Mechelen, Belgium, 16 May 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials
16/05/2019
Sym021 a novel anti-PD1 compound currently in Phase 1 clinical trials Copenhagen, 16 May 2019 – Symphogen, a private clinical stage oncology focused biopharmaceutical company with a productive antibody discovery engine [...]

Pages